The Nobel Assembly at Karolinska Institutet of Sweden has awarded the Nobel Prize in physiology or medicine to three scientists at U.S. universities for unraveling the intricacies behind how molecules are transported in the cell and delivered to the right place at the right time.
A stealth biotech spun out of Stanford University burst into public view today, drawing headlines around the world for its new therapeutic approach to Type 1 diabetes that aims to completely change the standard of care in the field.
A team of researchers at the Stanford University School of Medicine has developed a data mining method that could divulge important information about possible drug side effects using records of interactions between doctors and patients.
Tech visionary Peter Thiel, recently named one of FierceBiotech 's top biotech billionaires and an early venture investor in Facebook, has chosen two recipients of the first round of grants of up to $350,000--Stealth Biosciences and Skyphrase, which are both developing innovative technologies that could have uses in the biopharma space.
A Stanford University research team has concocted a new process that allowed them to make a mouse's brain completely transparent to the point of seeing detailed neuronal networks inside.
Personalis emerged from the crowd of new genomic analysis outfits with news of a contract from the U.S. Department of Veterans Affairs (VA).
Bone marrow stem cells may provide a way to target and treat inactive tuberculosis, which can hide in the body and emerge later on down the road, well after aggressive drug therapy.
Dr. Atul Butte is pioneering efforts from his lab at Stanford and via a startup called NuMedii--which is led by his wife, Gini Deshpande--to mine massive data sets for breakthrough diagnostics and treatments.
Today, doctors ask patients to rate their own pain on a scale, relying heavily on what patients say to make their diagnoses. Stanford researchers are working on a more objective measurement, and they have applied computer algorithms to help them pull it off.
Stanford University has won approval for a genomics center that will compete with MIT and Harvard's Broad Institute for funding and talent, The Stanford Daily reported. The West Coast rival will be explicitly focused on analyzing Big Data, those incredibly large and fast-growing data sets that scientists are investigating to solve mysteries about human biology and other complex fields.